catalpol has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, L; Wang, X; Wu, F; Zhong, W; Zou, G | 1 |
1 other study(ies) available for catalpol and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Catalpol attenuates cardiomyocyte apoptosis in diabetic cardiomyopathy via Neat1/miR-140-5p/HDAC4 axis.
Topics: Animals; Apoptosis; Cardiotonic Agents; Diabetic Cardiomyopathies; Histone Deacetylases; Iridoid Glucosides; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; RNA, Long Noncoding | 2019 |